Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Lung transplantation (LTx) is a therapeutic option for patients with life-threatening chronic obstructive pulmonary disease (COPD) that is refractory to conventional therapies. The survival benefit of LTx for COPD is difficult to assess. The aim of this study was to evaluate the Swedish series of LTx performed to treat COPD and to identify differences in outcome between COPD related to severe alpha-1-antitrypsin deficiency (AATD) and COPD with normal alpha-1-antitrypsin (AAT) levels.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Lungmedicin och allergi
Originalspråkengelska
Sidor (från-till)1930-1935
TidskriftAnnals of Thoracic Surgery
Volym98
Utgåva nummer6
StatusPublished - 2014
PublikationskategoriForskning
Peer review utfördJa